The USPTO ruling “no interference in fact” in the CRISPR patents dispute, the unveiling of a new non-profit devoted to increasing awareness of IP rights, Alibaba accusing agencies of filing false complaints, IBM’s Manny Schecter calling for Congress to act on Section 101, and new patent case rules in the Northern District of California were in the intellectual property news in the past week
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires